Showing 8141-8150 of 9895 results for "".
- EADV News: Psoriasis Largely Undertreated, Travels with Anxietyhttps://practicaldermatology.com/news/eadv-news-psoriasis-largely-undertreated-travels-with-anxiety/2460175/Many psoriasis patients remain un- or undertreated, with an average diagnosis time of five years, according to research presented at the 28th European Dermato-Venereology Society Congress in Madrid. In the study of 650 psoriasis patients in Germany, more than half of patients (56 percen
- Pediatric AD Takes Its Toll on Caregiver Emotional Wellbeinghttps://practicaldermatology.com/news/ad-takes-its-toll-on-caregiver-emotional-wellbeing/2460173/Family members and caregivers of children with atopic dermatitis (AD) may be at increased risk for anxiety and depression, according to new research presented at the 28th European Dermato-Venereology Society Congress in Madrid. Researchers from the PHIUniversity Clinic of Dermatol
- EADV News: Diet Linked to Acnehttps://practicaldermatology.com/news/eadv-news-diet-linked-to-acne/2460172/Consuming dairy products, sweets, soda or juice daily may increase risk for developing acne, according to research presented at the 28th European Dermato-Venereology Society Congress in Madrid. The study, which included of more than 6,700 participants across six countries in North
- Daily Almond Consumption May Reduce Facial Wrinkleshttps://practicaldermatology.com/news/daily-almond-consumption-may-reduce-facial-wrinkles/2460165/Snacking on almonds may help postmenopausal women smooth wrinkles from the inside out, according to a new study funded by the Almond Board of California. In this 16-week randomized controlled trial, 28 healthy
- La Roche-Posay Foundation Opens Call for Abstractshttps://practicaldermatology.com/news/la-roche-posay-foundation-opens-call-for-abstracts/2460163/The La Roche-Posay North American Foundation has opened a call for scientific abstracts. The La Roche-Posay North American Foundation was established in 2005 to support outstanding candidates with promising projects in the field of clinical, biological or pharmacological research linked to
- Electric Tech May Help Reverse Baldnesshttps://practicaldermatology.com/news/electric-tech-may-help-reverse-baldness/2460156/Reversing baldness could someday be as easy as wearing a hat, thanks to a noninvasive, low-cost hair-growth-stimulating technology developed by engineers at the University of Wisconsin–Madison. Xudong Wang, a professor of materials science and engineering at UW–Madison. and
- Pediatric Dermatologist Who Co-Founded Camp for Children Recognized for Carehttps://practicaldermatology.com/news/pediatric-dermatologist-who-co-founded-camp-for-children-recognized-for-care/2460153/The American Academy of Dermatology honored dermatologist Karen Wiss, MD, FAAD, as a Patient Care Hero for her role in treating a patient with recessive dystrophic epidermolysis bullosa (RDEB). To support pediatric patients with isolating conditions like RDEB, Dr. Wiss, a derm
- Dr. Richard M. Goldfarb Named Medical Director of DBM Corporationhttps://practicaldermatology.com/news/dr-richard-m-goldfarb-named-medical-director-ofdbm-corporation/2460145/Richard M. Goldfarb MD, is the new Medical Director of DBM Corporation Inc. is the official US representative of MIRACU PDO Threads. In this role, Dr. Goldfarb, the founder of the Center for SmartLipo & Plastic Surgery in the Philadelphia
- DermTech Closes Combination with Constellation Alpha Capital Corphttps://practicaldermatology.com/news/dermtech-closes-combination-with-constellation-alpha-capital-corp/2460138/DermTech, Inc., a precision dermatology company enabled by a non-invasive skin genomics platform, has completed its previously announced business combination with Constellation Alpha Capital Corp., a publicly traded special purpose acquisition company prior to the business combination. As a resul
- Amgen To Acquire Otezla® For $13.4 Billion In Cashhttps://practicaldermatology.com/news/amgen-to-acquire-otezla-for-134-billion-in-cash/2460135/Amgen has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers Squibb Company </